Elacridar (Standard)
Based on 1 Customer Validation
Elacridar (Standard) is the analytical standard of Elacridar. This product is intended for research and analytical applications. Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza : 97.50%
- No. CAS: 143664-11-3
- Fòrmula: C34H33N3O5
- Peso molecular:563.64
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureza y Documentación
-
Help & FAQs
-
HY-50879
ElacridarP-gp And BCRP Dual-Inhibitor -
HY-10010
Ko 143BCRP/ABCG2 Inhibitor -
HY-10550
TariquidarP-gp Inhibitor -
HY-13646
EncequidarP-glycoprotein Inhibitor -
HY-50880
Elacridar hydrochlorideP-gp And BCRP Dual-Inhibitor -
HY-17384
ValspodarP-glycoprotein Inhibitor -
HY-15255
ZosuquidarP-gp Inhibitor -
HY-50671
Zosuquidar trihydrochlorideP-gp Inhibitor -
HY-107643
ReversanPgp Inhibitor; MRP1 Inhibitor -
HY-13646A
Encequidar mesylateP-gp Inhibitor -
HY-10550A
Tariquidar methanesulfonate, hydrateP-gp Inhibitor -
HY-17013
DofequidarP-glycoprotein Inhibitor
Product Information
Information
Aplicación
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
No. CAS 143664-11-3
-
Appearance Solid
-
Peso molecular 563.64
-
Fòrmula C34H33N3O5
-
Color Light yellow to yellow
-
SMILES
O=C1C2=CC=CC(C(NC(C=C3)=CC=C3CCN4CC(C=C(C(OC)=C5)OC)=C5CC4)=O)=C2NC6=C1C=CC=C6OC
-
Synonyms
GF120918 (Standard); GW0918 (Standard); GG918 (Standard); GW120918 (Standard)
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
-
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
[1]. Sane R, et al. Brain distribution and bioavailability of elacridar after different routes of administration in the mouse. Drug Metab Dispos. 2012 Aug;40(8):1612-9. [Content Brief]
[2]. Sato H, et al. Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells. Eur J Pharmacol. 2015 Jan 5;746:258-66. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Elacridar (Standard) Related Classifications
HY-50879R Related Classifications
Powered by Bioz